Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria L Padilla

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Pediatric Blood & Cancer|April 18, 2024
Pleuroparenchymal fibroelastosis as a late complication of childhood cancer therapy: A case seriesPriya H Marathe, Valeria Santibanez, Paul A Meyers, et al.
Chest|September 16, 2005
Distinctive clinical, radiographic, and functional characteristics of patients with sarcoidosis-related pulmonary hypertensionRoxana Sulica, Alvin S Teirstein, Shudhir Kakarla, et al.
Chest|October 11, 2007
Results of 188 whole-body fluorodeoxyglucose positron emission tomography scans in 137 patients with sarcoidosisAlvin S Teirstein, Josef Machac, Orlandino Almeida, et al.
Canadian Respiratory Journal|September 20, 2019
Concomitant Interstitial Lung Disease with PsoriasisGenta Ishikawa, Sakshi Dua, Aditi Mathur, et al.
Current Problems in Diagnostic Radiology|December 17, 2014
Idiopathic interstitial pneumonias: a radiology-pathology correlation based on the revised 2013 American Thoracic Society-European Respiratory Society classification systemMichael A Kadoch, Matthew D Cham, Mary B Beasley, et al.
Pulmonary Therapy|February 7, 2020
An Open-Label, Phase II Study of the Safety of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis (PIPF-002)Mark H Gotfried, Carlos E Girod, Danielle Antin-Ozerkis, et al.
European Respiratory Review : an Official Journal of the European Respiratory Society|December 23, 2018
Acute exacerbations of progressive-fibrosing interstitial lung diseasesMartin Kolb, Benjamin Bondue, Alberto Pesci, et al.
European Respiratory Review : an Official Journal of the European Respiratory Society|December 8, 2017
Pirfenidone safety and adverse event management in idiopathic pulmonary fibrosisLisa H Lancaster, Joao A de Andrade, Joseph D Zibrak, et al.
BMC Pulmonary Medicine|July 16, 2020
Expert consensus on the management of adverse events and prescribing practices associated with the treatment of patients taking pirfenidone for idiopathic pulmonary fibrosis: a Delphi consensus studyFranck F Rahaghi, Zeenat Safdar, Anne Whitney Brown, et al.
Annals of the American Thoracic Society|June 19, 2026
Nintedanib in Post-COVID Interstitial Lung Disease: a double-blind, randomized, placebo-controlled Clinical TrialSusan K Mathai, Sean J Callahan, Helena Chang, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Pediatric Blood & Cancer|April 18, 2024
Pleuroparenchymal fibroelastosis as a late complication of childhood cancer therapy: A case seriesPriya H Marathe, Valeria Santibanez, Paul A Meyers, et al.
Chest|September 16, 2005
Distinctive clinical, radiographic, and functional characteristics of patients with sarcoidosis-related pulmonary hypertensionRoxana Sulica, Alvin S Teirstein, Shudhir Kakarla, et al.
Chest|October 11, 2007
Results of 188 whole-body fluorodeoxyglucose positron emission tomography scans in 137 patients with sarcoidosisAlvin S Teirstein, Josef Machac, Orlandino Almeida, et al.
Canadian Respiratory Journal|September 20, 2019
Concomitant Interstitial Lung Disease with PsoriasisGenta Ishikawa, Sakshi Dua, Aditi Mathur, et al.
Current Problems in Diagnostic Radiology|December 17, 2014
Idiopathic interstitial pneumonias: a radiology-pathology correlation based on the revised 2013 American Thoracic Society-European Respiratory Society classification systemMichael A Kadoch, Matthew D Cham, Mary B Beasley, et al.
Pulmonary Therapy|February 7, 2020
An Open-Label, Phase II Study of the Safety of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis (PIPF-002)Mark H Gotfried, Carlos E Girod, Danielle Antin-Ozerkis, et al.
European Respiratory Review : an Official Journal of the European Respiratory Society|December 23, 2018
Acute exacerbations of progressive-fibrosing interstitial lung diseasesMartin Kolb, Benjamin Bondue, Alberto Pesci, et al.
European Respiratory Review : an Official Journal of the European Respiratory Society|December 8, 2017
Pirfenidone safety and adverse event management in idiopathic pulmonary fibrosisLisa H Lancaster, Joao A de Andrade, Joseph D Zibrak, et al.
BMC Pulmonary Medicine|July 16, 2020
Expert consensus on the management of adverse events and prescribing practices associated with the treatment of patients taking pirfenidone for idiopathic pulmonary fibrosis: a Delphi consensus studyFranck F Rahaghi, Zeenat Safdar, Anne Whitney Brown, et al.
Annals of the American Thoracic Society|June 19, 2026
Nintedanib in Post-COVID Interstitial Lung Disease: a double-blind, randomized, placebo-controlled Clinical TrialSusan K Mathai, Sean J Callahan, Helena Chang, et al.
Pageof 3